The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

The U.S. Centers for Medicare & Medicaid Services, or CMS, said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated under the Inflation ...

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.

The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Those drugs are: Ozempic/Wegovy/Rybelsus ... Novo Nordisk said the company "remains opposed to government price setting through the (Inflation Reduction Act) and has significant concerns about how the ...